On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.

NetworkNewsBreaks – Plus Therapeutics, Inc. (NASDAQ: PSTV) Changes Name, Ticker Symbol; Details Reverse Stock Split

Company: Plus Therapeutics, Inc. (PSTV)
Category: News

Plus Therapeutics, (NASDAQ: PSTV) announced that it has officially changed its name from Cytori Therapeutics, Inc. to Plus Therapeutics, Inc. The company’s ticker symbol for its common stock on the Nasdaq Capital Market changed from ‘CYTX’ to ‘PSTV’ and the ticker symbol for its Series S Warrants changed from ‘CYTXZ’ to ‘PSTVZ’. In the news release, Plus Therapeutics detailed its plans to make a 1-for-50 reverse stock split become effective on August 5, 2019, transforming every 50 shares of the company’s common stock into one issued and outstanding share without any change in the par value of the shares. Following the reverse stock split, the company anticipated that the number of outstanding shares of its common stock would be proportionally reduced from approximately 22.2 million to approximately 0.4 million.

To view the full press release, visit http://nnw.fm/rvS5w

About Plus Therapeutics, Inc.

Plus Therapeutics is a clinical-stage pharmaceutical company focused on making a positive impact on patients’ lives and adding value to the healthcare system. Plus Therapeutics is a Nasdaq-listed company with headquarters located in Austin, TX. Plus also has a manufacturing facility in San Antonio, TX and a satellite office in San Diego, CA. The lead product candidate in the company’s pipeline, DocePLUS, is being developed in the U.S. by a dedicated and energetic team of biologists, chemists, engineers, and other professionals. This diverse and experienced team is using the company’s proprietary and versatile nanotechnology platform in an effort to reformulate and improve conventional, workhorse chemotherapeutics to provide meaningful benefits to patients and healthcare providers. The platform also serves as the foundation and affords the company the opportunity in the future to develop additional drugs for oncology and other therapeutic areas. For more information, visit the company’s website at www.PlusTherapeutics.com.

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217